MedTrace Logo

Copeptin in Normal- to Hyperosmolar States

NCT02647736 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2016-08-03

No results posted yet for this study

Summary

Kinetics of Copeptin in response to osmotic alterations in healthy volunteers

Conditions

  • Copeptin Blood Values

Interventions

OTHER

Hypertonic saline infusion

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Mirjam Christ-Crain, Prof. · University Hospital, Basel, Switzerland

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2016-07-31

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02647736 on ClinicalTrials.gov